DRUG · Unmapped registry intervention
VESIcare 10Mg Tablet
Find medicine records ·
Find other trials using this name
Clinical trial
Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis
NCT04819360
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Botox 100 UNT Injection
Normalized identity: onabotulinumtoxinA 100 UNT Injection [Botox]View linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedBotulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Urinary Bladder, Neurogenicunresolved
Multiple Sclerosisverified · MONDO: multiple sclerosis
Interventions
Sponsors & collaborators
Brigitte Schürchlead sponsor
Centre Hospitalier Universitaire Vaudoiscollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04819360 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.